1 option
COVID-19 clinical trial combines remdesivir with anti-inflammatory drug for one-two punch at SLU.
- Format:
- Video
- Language:
- English
- Subjects (All):
- COVID-19 (Disease)--Treatment.
- COVID-19 (Disease).
- Antiviral agents.
- Anti-inflammatory agents.
- Physical Description:
- 1 online resource (1 video file (00:03:53)) : sound, colour
- Other Title:
- COVID-19 clinical trial combines remdesivir with anti-inflammatory drug for one-two punch at Saint Louis University
- Place of Publication:
- [Place of publication not identified] : Educate Today, 2020.
- Language Note:
- Closed-captioned in English.
- Summary:
- Kathleen Berger and Dr. Sarah George, MD, discuss a clinical trial that combines remdesivir, an experimental antiviral medication developed to treat Ebola, with baricitinib, an anti-inflammatory drug, as a treatment for COVID-19.
- Participant:
- Practitioner, Sarah George MD.
- Narrator, Kathleen Berger.
- Notes:
- Description based on XML content.
- ISBN:
- 9781529790054 (streaming video) :
- 9781529790054
- OCLC:
- 1266871008
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.